Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
•
Primary Care
How do you manage a patient who is reliant on NSAIDs for arthritis but has developed PUD?
Would you consider COX-2 selective inhibition, PPI, PCAB, or some combination thereof?
Related Questions
Would you pursue a colonoscopy for a patient in their 20s with constipation and rectal bleeding if they had a first-degree relative who died young from a "carcinoid tumor"?
How do you further workup and treat a patient with nausea and weight loss found to have granulomatous gastritis on endoscopic biopsies with a negative workup for sarcoidosis or Crohn's disease?
What adjunctive therapies beyond an antisecretory agent (e.g., PPI, H2RA, etc.) do you find most helpful in managing the acute symptoms of PUD?
Is there a particular prokinetic agent that you recommend if a patient has failed both PPI and TCA in the treatment of suspected functional dyspepsia?
What diet do you recommend for patients with inflammatory bowel disease?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?
How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?
Do you routinely check vitamin K levels in post-bariatric surgery patients?
What is your advice to patients with IBD who are on biologic therapies and planning for pregnancy?